Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists
ROBERT A. COPELAND, PhD, is Executive Vice President and Chief Scientific Officer at Epizyme, Inc., a biopharmaceutical company in Cambridge, Massachusetts. He is on the Editorial Board of The Journal of Biological Chemistry and a member of the Faculty of 1000. Dr. Copeland has contributed more than...
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Somerset
John Wiley & Sons, Incorporated
2013
|
| Edition: | 2nd ed |
| Subjects: | |
| Summary: | ROBERT A. COPELAND, PhD, is Executive Vice President and Chief Scientific Officer at Epizyme, Inc., a biopharmaceutical company in Cambridge, Massachusetts. He is on the Editorial Board of The Journal of Biological Chemistry and a member of the Faculty of 1000. Dr. Copeland has contributed more than 175 publications to the scientific literature and holds eight U.S.-issued patents. He has authored several books in protein science and enzymology, including Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, Second Edition (Wiley) |
| Item Description: | Description based on publisher supplied metadata and other sources |
| Physical Description: | 1 online resource (527 pages) |
| ISBN: | 9781118540282 9781118488133 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044050025 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2013 |||| o||u| ||||||eng d | ||
| 020 | |a 9781118540282 |9 978-1-118-54028-2 | ||
| 020 | |a 9781118488133 |c Print |9 978-1-118-48813-3 | ||
| 035 | |a (ZDB-30-PAD)EBC1120975 | ||
| 035 | |a (ZDB-89-EBL)EBL1120975 | ||
| 035 | |a (ZDB-38-EBR)ebr10662577 | ||
| 035 | |a (OCoLC)818327396 | ||
| 035 | |a (DE-599)BVBBV044050025 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 615.19 | |
| 100 | 1 | |a Copeland, Robert A. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Evaluation of Enzyme Inhibitors in Drug Discovery |b A Guide for Medicinal Chemists and Pharmacologists |
| 250 | |a 2nd ed | ||
| 264 | 1 | |a Somerset |b John Wiley & Sons, Incorporated |c 2013 | |
| 264 | 4 | |c © 2013 | |
| 300 | |a 1 online resource (527 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Description based on publisher supplied metadata and other sources | ||
| 520 | |a ROBERT A. COPELAND, PhD, is Executive Vice President and Chief Scientific Officer at Epizyme, Inc., a biopharmaceutical company in Cambridge, Massachusetts. He is on the Editorial Board of The Journal of Biological Chemistry and a member of the Faculty of 1000. Dr. Copeland has contributed more than 175 publications to the scientific literature and holds eight U.S.-issued patents. He has authored several books in protein science and enzymology, including Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, Second Edition (Wiley) | ||
| 650 | 4 | |a Drugs -- Design | |
| 650 | 4 | |a Enzyme inhibitors -- Therapeutic use -- Testing | |
| 650 | 0 | 7 | |a Enzyminhibitor |0 (DE-588)4152479-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Enzyminhibitor |0 (DE-588)4152479-2 |D s |
| 689 | 0 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Copeland, Robert A. |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Copeland, Robert A |t . Evaluation of Enzyme Inhibitors in Drug Discovery : A Guide for Medicinal Chemists and Pharmacologists |
| 912 | |a ZDB-30-PAD |a ZDB-38-ESG | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029456870 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Record in the Search Index
| _version_ | 1804177067064950784 |
|---|---|
| any_adam_object | |
| author | Copeland, Robert A. |
| author_facet | Copeland, Robert A. |
| author_role | aut |
| author_sort | Copeland, Robert A. |
| author_variant | r a c ra rac |
| building | Verbundindex |
| bvnumber | BV044050025 |
| collection | ZDB-30-PAD ZDB-38-ESG |
| ctrlnum | (ZDB-30-PAD)EBC1120975 (ZDB-89-EBL)EBL1120975 (ZDB-38-EBR)ebr10662577 (OCoLC)818327396 (DE-599)BVBBV044050025 |
| dewey-full | 615.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.19 |
| dewey-search | 615.19 |
| dewey-sort | 3615.19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 2nd ed |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02409nmm a2200481zc 4500</leader><controlfield tag="001">BV044050025</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2013 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118540282</subfield><subfield code="9">978-1-118-54028-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118488133</subfield><subfield code="c">Print</subfield><subfield code="9">978-1-118-48813-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC1120975</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL1120975</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-38-EBR)ebr10662577</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)818327396</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044050025</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.19</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Copeland, Robert A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Evaluation of Enzyme Inhibitors in Drug Discovery</subfield><subfield code="b">A Guide for Medicinal Chemists and Pharmacologists</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2nd ed</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Somerset</subfield><subfield code="b">John Wiley & Sons, Incorporated</subfield><subfield code="c">2013</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (527 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">ROBERT A. COPELAND, PhD, is Executive Vice President and Chief Scientific Officer at Epizyme, Inc., a biopharmaceutical company in Cambridge, Massachusetts. He is on the Editorial Board of The Journal of Biological Chemistry and a member of the Faculty of 1000. Dr. Copeland has contributed more than 175 publications to the scientific literature and holds eight U.S.-issued patents. He has authored several books in protein science and enzymology, including Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, Second Edition (Wiley)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs -- Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enzyme inhibitors -- Therapeutic use -- Testing</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Enzyminhibitor</subfield><subfield code="0">(DE-588)4152479-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Enzyminhibitor</subfield><subfield code="0">(DE-588)4152479-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Copeland, Robert A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Copeland, Robert A</subfield><subfield code="t">. Evaluation of Enzyme Inhibitors in Drug Discovery : A Guide for Medicinal Chemists and Pharmacologists</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield><subfield code="a">ZDB-38-ESG</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029456870</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV044050025 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:42:11Z |
| institution | BVB |
| isbn | 9781118540282 9781118488133 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029456870 |
| oclc_num | 818327396 |
| open_access_boolean | |
| physical | 1 online resource (527 pages) |
| psigel | ZDB-30-PAD ZDB-38-ESG |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | John Wiley & Sons, Incorporated |
| record_format | marc |
| spelling | Copeland, Robert A. Verfasser aut Evaluation of Enzyme Inhibitors in Drug Discovery A Guide for Medicinal Chemists and Pharmacologists 2nd ed Somerset John Wiley & Sons, Incorporated 2013 © 2013 1 online resource (527 pages) txt rdacontent c rdamedia cr rdacarrier Description based on publisher supplied metadata and other sources ROBERT A. COPELAND, PhD, is Executive Vice President and Chief Scientific Officer at Epizyme, Inc., a biopharmaceutical company in Cambridge, Massachusetts. He is on the Editorial Board of The Journal of Biological Chemistry and a member of the Faculty of 1000. Dr. Copeland has contributed more than 175 publications to the scientific literature and holds eight U.S.-issued patents. He has authored several books in protein science and enzymology, including Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, Second Edition (Wiley) Drugs -- Design Enzyme inhibitors -- Therapeutic use -- Testing Enzyminhibitor (DE-588)4152479-2 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Enzyminhibitor (DE-588)4152479-2 s Arzneimittelentwicklung (DE-588)4143176-5 s 1\p DE-604 Copeland, Robert A. Sonstige oth Erscheint auch als Druck-Ausgabe Copeland, Robert A . Evaluation of Enzyme Inhibitors in Drug Discovery : A Guide for Medicinal Chemists and Pharmacologists 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Copeland, Robert A. Evaluation of Enzyme Inhibitors in Drug Discovery A Guide for Medicinal Chemists and Pharmacologists Drugs -- Design Enzyme inhibitors -- Therapeutic use -- Testing Enzyminhibitor (DE-588)4152479-2 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| subject_GND | (DE-588)4152479-2 (DE-588)4143176-5 |
| title | Evaluation of Enzyme Inhibitors in Drug Discovery A Guide for Medicinal Chemists and Pharmacologists |
| title_auth | Evaluation of Enzyme Inhibitors in Drug Discovery A Guide for Medicinal Chemists and Pharmacologists |
| title_exact_search | Evaluation of Enzyme Inhibitors in Drug Discovery A Guide for Medicinal Chemists and Pharmacologists |
| title_full | Evaluation of Enzyme Inhibitors in Drug Discovery A Guide for Medicinal Chemists and Pharmacologists |
| title_fullStr | Evaluation of Enzyme Inhibitors in Drug Discovery A Guide for Medicinal Chemists and Pharmacologists |
| title_full_unstemmed | Evaluation of Enzyme Inhibitors in Drug Discovery A Guide for Medicinal Chemists and Pharmacologists |
| title_short | Evaluation of Enzyme Inhibitors in Drug Discovery |
| title_sort | evaluation of enzyme inhibitors in drug discovery a guide for medicinal chemists and pharmacologists |
| title_sub | A Guide for Medicinal Chemists and Pharmacologists |
| topic | Drugs -- Design Enzyme inhibitors -- Therapeutic use -- Testing Enzyminhibitor (DE-588)4152479-2 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| topic_facet | Drugs -- Design Enzyme inhibitors -- Therapeutic use -- Testing Enzyminhibitor Arzneimittelentwicklung |
| work_keys_str_mv | AT copelandroberta evaluationofenzymeinhibitorsindrugdiscoveryaguideformedicinalchemistsandpharmacologists |